Consciousness and metarepresentation: a computational sketch
Abstract
When one is conscious of something, one is also conscious that one is conscious. Higher-Order Thought Theory [Rosenthal, D. (1997). A theory of consciousness. In N. Block, O. Flanagan, & G. Güzeldere (Eds.), The nature of consciousness: Philosophical debates. Cambridge, MA: MIT Press] takes it that it is in virtue of the fact that one is conscious of being conscious, that one is conscious. Here, we ask what the computational mechanisms may be that implement this intuition. Our starting point is Clark and Karmiloff-Smith's [Clark, A., & Karmiloff-Smith, A. (1993). The cognizer's innards: A psychological and philosophical perspective on the development of thought. Mind and Language, 8, 487-519] point that knowledge acquired by a connectionist network always remains "knowledge in the network rather than knowledge for the network". That is, while connectionist networks may become exquisitely sensitive to regularities contained in their input-output environment, they never exhibit the ability to access and manipulate this knowledge as knowledge: The knowledge can only be expressed through performing the task upon which the network was trained; it remains forever embedded in the causal pathways that developed as a result of training. To address this issue, we present simulations in which two networks interact. The states of a first-order network trained to perform a simple categorization task become input to a second-order network trained either as an encoder or on another…
How strong is the evidence?
Evidence Hub reads this as a simulation / modelling, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.